This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Mitogen-activated protein kinase

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
 
+
<StructureSection load='2ojg' size='350' side='right' caption='Human MAPK1 complex with inhibitor and sulfate (PDB entry [[2ojg]])' scene=''>
-
<StructureSection load='2ojg' size='350' side='right' caption='Human α-defensin 1 (PDB entry [[2pm4]])' scene=''>
+
== Function ==
== Function ==
[[Mitogen-activated protein kinase]] (MAPK) also known as '''Extracellular Signal-Regulated Kinase (ERK)''' are serine/threonine kinases which regulate various cellular activities in response to extracellular stimuli by mitogens, heat shock and more. MAPK is part of the MAPK cascade which consists of MAPK, [[Mitogen-activated protein kinase kinase|MAP2K]] and [[Mitogen-activated protein kinase kinase kinase|MAP3K]] which are activated by phosphorylation<ref>PMID:9069255</ref>. <br />
[[Mitogen-activated protein kinase]] (MAPK) also known as '''Extracellular Signal-Regulated Kinase (ERK)''' are serine/threonine kinases which regulate various cellular activities in response to extracellular stimuli by mitogens, heat shock and more. MAPK is part of the MAPK cascade which consists of MAPK, [[Mitogen-activated protein kinase kinase|MAP2K]] and [[Mitogen-activated protein kinase kinase kinase|MAP3K]] which are activated by phosphorylation<ref>PMID:9069255</ref>. <br />
Line 15: Line 14:
== Disease ==
== Disease ==
MAPK14 is associated with acquired hyperkeratosis and prostate transitional cell carcinoma.
MAPK14 is associated with acquired hyperkeratosis and prostate transitional cell carcinoma.
 +
 +
== Structural highlights ==
 +
Inhibitors of MAPK bind in its ATP-binding site<ref>PMID:17300186</ref>.
 +
</StructureSection>
== 3D Structures of Mitogen-activated protein kinase ==
== 3D Structures of Mitogen-activated protein kinase ==

Revision as of 07:35, 28 April 2016

Human MAPK1 complex with inhibitor and sulfate (PDB entry 2ojg)

Drag the structure with the mouse to rotate

3D Structures of Mitogen-activated protein kinase

Updated on 28-April-2016

References

  1. Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 1997 Apr;9(2):180-6. PMID:9069255
  2. Aronov AM, Baker C, Bemis GW, Cao J, Chen G, Ford PJ, Germann UA, Green J, Hale MR, Jacobs M, Janetka JW, Maltais F, Martinez-Botella G, Namchuk MN, Straub J, Tang Q, Xie X. Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors. J Med Chem. 2007 Mar 22;50(6):1280-7. Epub 2007 Feb 15. PMID:17300186 doi:http://dx.doi.org/10.1021/jm061381f

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Joel L. Sussman

Personal tools